Phosphorylation of TRAF2 Within Its RING Domain Inhibits Stress-induced Cell Death by Promoting IKK and Suppressing JNK Activation

Overview

Journal Cancer Res

Specialty Oncology

Date 2009 Apr 2

PMID 19336568

Citations 18

Authors

Gregory S Thomas

Laiqun Zhang

Ken Blackwell

Hasem Habelhah

Affiliations

Soon will be listed here.

Abstract

Tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2) is an adaptor protein that modulates the activation of the c-Jun NH(2) terminal kinase (JNK)/c-Jun and IkappaB kinase (IKK)/nuclear factor-kappaB (NF-kappaB) signaling cascades in response to TNFalpha stimulation. Although many serine/threonine kinases have been implicated in TNFalpha-induced IKK activation and NF-kappaB-dependent gene expression, most of them do not directly activate IKK. Here, we report that protein kinase Czeta phosphorylates TRAF2 at Ser(55), within the RING domain of the protein, after TNFalpha stimulation. Although this phosphorylation event has a minimal effect on induction of the immediate/transient phase of IKK and JNK activation by TNFalpha, it promotes the secondary/prolonged phase of IKK activation and inhibits that of JNK. Importantly, constitutive TRAF2 phosphorylation increased both basal and inducible NF-kappaB activation and rendered Ha-Ras-V12-transformed cells resistant to stress-induced apoptosis. Moreover, TRAF2 was found to be constitutively phosphorylated in some malignant cancer cell lines and Hodgkin's lymphoma. These results reveal a new level of complexity in TNFalpha-induced IKK activation modulated by TRAF2 phosphorylation and suggest that TRAF2 phosphorylation is one of the events that are responsible for elevated basal NF-kappaB activity in certain human cancers.

Citing Articles

TNF Receptor Associated Factor 2 (TRAF2) Signaling in Cancer.

Siegmund D, Wagner J, Wajant H Cancers (Basel). 2022; 14(16).

PMID: 36011046 PMC: 9406534. DOI: 10.3390/cancers14164055.

Single nucleotide polymorphisms of TRAF2 and TRAF5 gene in ankylosing spondylitis: a case-control study.

Xu S, Kong J, Huang L, Xie H, Wang F, Zhou T Clin Exp Med. 2021; 21(4):645-653.

PMID: 33997937 DOI: 10.1007/s10238-021-00719-7.

TRAF2 Ser-11 Phosphorylation Promotes Cytosolic Translocation of the CD40 Complex To Regulate Downstream Signaling Pathways.

Workman L, Zhang L, Fan Y, Zhang W, Habelhah H Mol Cell Biol. 2020; 40(9).

PMID: 32041822 PMC: 7156217. DOI: 10.1128/MCB.00429-19.

PKCζ phosphorylates TRAF2 to protect against intestinal ischemia-reperfusion-induced injury.

Zhou W, Yao J, Wang G, Chen Z, Li Z, Feng D Cell Death Dis. 2017; 8(7):e2935.

PMID: 28726782 PMC: 5550857. DOI: 10.1038/cddis.2017.310.

Genome-wide methylome and chromatin interactome identify abnormal enhancer to be risk factor of breast cancer.

Wang Y, Hao D, Li J, Wang L, Di L Oncotarget. 2017; 8(27):44705-44719.

PMID: 28621677 PMC: 5546512. DOI: 10.18632/oncotarget.18348.

References

Greten F, Eckmann L, Greten T, Park J, Li Z, Egan L . IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004; 118(3):285-96. DOI: 10.1016/j.cell.2004.07.013. View

Orlowski R, Baldwin Jr A . NF-kappaB as a therapeutic target in cancer. Trends Mol Med. 2002; 8(8):385-9. DOI: 10.1016/s1471-4914(02)02375-4. View

Chen Z . Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol. 2005; 7(8):758-65. PMC: 1551980. DOI: 10.1038/ncb0805-758. View

Sakon S, Xue X, Takekawa M, Sasazuki T, Okazaki T, Kojima Y . NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J. 2003; 22(15):3898-909. PMC: 169052. DOI: 10.1093/emboj/cdg379. View

Tada K, Okazaki T, Sakon S, Kobarai T, Kurosawa K, Yamaoka S . Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-kappa B activation and protection from cell death. J Biol Chem. 2001; 276(39):36530-4. DOI: 10.1074/jbc.M104837200. View

Moscat J, Rennert P, Diaz-Meco M . PKCzeta at the crossroad of NF-kappaB and Jak1/Stat6 signaling pathways. Cell Death Differ. 2005; 13(5):702-11. DOI: 10.1038/sj.cdd.4401823. View

Aggarwal B . Nuclear factor-kappaB: the enemy within. Cancer Cell. 2004; 6(3):203-8. DOI: 10.1016/j.ccr.2004.09.003. View

Horie R, Watanabe T, Ito K, Morisita Y, Watanabe M, Ishida T . Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells. Am J Pathol. 2002; 160(5):1647-54. PMC: 1850879. DOI: 10.1016/S0002-9440(10)61112-1. View

Tan S, Parker P . Emerging and diverse roles of protein kinase C in immune cell signalling. Biochem J. 2003; 376(Pt 3):545-52. PMC: 1223826. DOI: 10.1042/BJ20031406. View

10.

Li S, Wang L, Berman M, Zhang Y, Dorf M . RNAi screen in mouse astrocytes identifies phosphatases that regulate NF-kappaB signaling. Mol Cell. 2006; 24(4):497-509. PMC: 2572259. DOI: 10.1016/j.molcel.2006.10.015. View

11.

Schechtman D, Mochly-Rosen D . Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene. 2001; 20(44):6339-47. DOI: 10.1038/sj.onc.1204778. View

12.

Bradley J, Pober J . Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene. 2001; 20(44):6482-91. DOI: 10.1038/sj.onc.1204788. View

13.

Moscat J, Diaz-Meco M, Rennert P . NF-kappaB activation by protein kinase C isoforms and B-cell function. EMBO Rep. 2003; 4(1):31-6. PMC: 1315804. DOI: 10.1038/sj.embor.embor704. View

14.

Wajant H, Henkler F, Scheurich P . The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators. Cell Signal. 2001; 13(6):389-400. DOI: 10.1016/s0898-6568(01)00160-7. View

15.

Leitges M, Sanz L, MARTIN P, Duran A, Braun U, Garcia J . Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway. Mol Cell. 2001; 8(4):771-80. DOI: 10.1016/s1097-2765(01)00361-6. View

16.

Lallena M, Diaz-Meco M, Bren G, Paya C, Moscat J . Activation of IkappaB kinase beta by protein kinase C isoforms. Mol Cell Biol. 1999; 19(3):2180-8. PMC: 84010. DOI: 10.1128/MCB.19.3.2180. View

17.

Cohen E, Lingen M, Zhu B, Zhu H, Straza M, Pierce C . Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase. Cancer Res. 2006; 66(12):6296-303. DOI: 10.1158/0008-5472.CAN-05-3139. View

18.

Bonizzi G, Karin M . The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004; 25(6):280-8. DOI: 10.1016/j.it.2004.03.008. View

19.

Esteve P, Chicoine E, Robledo O, Aoudjit F, Descoteaux A, Potworowski E . Protein kinase C-zeta regulates transcription of the matrix metalloproteinase-9 gene induced by IL-1 and TNF-alpha in glioma cells via NF-kappa B. J Biol Chem. 2002; 277(38):35150-5. DOI: 10.1074/jbc.M108600200. View

20.

Barradas M, Monjas A, Diaz-Meco M, Serrano M, Moscat J . The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression. EMBO J. 1999; 18(22):6362-9. PMC: 1171699. DOI: 10.1093/emboj/18.22.6362. View